Sign in with Google
bullish
Divi's Laboratories (DIVI IN): Custom Synthesis Business to Drive Future Growth
375 Views02 Jun 2024 17:32
SUMMARY
- Divi's Laboratories (DIVI IN) reported steady performance in Q4FY24, marked by YoY and sequential growth in revenue and improvement in profitability. Double-digit growth is expected to continue.
- Custom Synthesis business grew 47% YoY and 38% QoQ to INR12B in Q4FY24, driven by increasing value realization from existing commercial projects and addition of new projects to the portfolio.
- In Custom Synthesis, Divi’s Lab is in the process of entering into a long-term supply agreement with an MNC customer and is planning for capacity addition at its manufacturing facility.
Related Insights
More »Loading
Trending Collections
More »Trending Insights
More »- TIP Customized Taiwan Select High Div Index Rebal Preview: Methodology Change Leads to US$9bn Trade
- From Rust to Riches: The Next Copper Boom
- [Japan Activism] Pasona Group (2168 JP) - Three New Things Of Mixed Importance
- ChiNext/ChiNext 50 Index Rebalance: US$1.3bn Round-Trip Trade
- FnGuide Top 10 & Equal Weight Index Rebalance Preview: Outperformance Continues
Top Unpaywalled Insights
More »- Advanced Look: Navigating the New Macro Landscape Through Quantitative Alpha Generation Strategies
- [IO Technicals 2025/22] Bearish Momentum Strengthens
- Texas Power Play: Grid Sovereignty, Bitcoin, and the Future of AI
- Overview #27 – The Big Beautiful Tragi-Comedy Continues
- Curator's Cut: Korea's Value, CATL's Charge and Copper's Surge
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Discussions
(Paid Plans Only)
x